ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Immune Tolerance Monitoring in Renal Allograft Tolerance Induced by Transient Mixed Chimerism in Nonhuman Primates and Humans.

    K. Hotta, T. Oura, K. Crisalli, D. Sachs, B. Cosim, T. Kawai.

    Center for Transplantation Science, Massachusetts General Hospital, Boston, MA.

    Background: Successful induction of allograft tolerance in MHC-mismatched kidney transplantation has been achieved after induction of transient chimerism in both nonhuman primates (NHP) and humans.…
  • 2016 American Transplant Congress

    Descriptive Epidemiology and Trends of Community Parenteral Antimicrobial Therapy Utilization Among Solid Organ Transplant Recipients at a High Volume Transplant Center 2008 to 2014.

    S. Mawhorter, N. Shrestha.

    Infectious Diseases, Cleveland Clinic, Cleveland, OH.

    INTRODUCTION: Solid organ transplant (SOT) recipients may benefit from community-based parenteral anti-infective therapy (CoPAT). Limited data are available. CoPAT may help reduce LOS. As a…
  • 2016 American Transplant Congress

    Metabolic Recovery and Ex Vivo Simulation of Early Liver Reperfusion.

    B. Bruinsma,1 J. Avruch,2 G. Sridharan,1 P. Weeder,1 N. Karimian,1 J. Markmann,2 K. Uygun,1 H. Yeh.2

    1Center for Engineering in Medicine, Massachusetts General Hospital, Boston, MA; 2Transplant Center, Massachusetts General Hospital, Boston, MA.

    Purpose. An urgent need for more liver grafts for transplantation has prompted the use of more suboptimal organs. Particularly in these more marginal livers adequate…
  • 2016 American Transplant Congress

    Genomic-Derived Markers to Identify Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients.

    E. Rhone,1 R. Gehrau,2 S. Bontha,2 P. Walker,3 C. Dumur,4 D. Maluf,2 V. Mas.2

    1Pediatrics, University of Virginia, Charlottesville, VA; 2Surgery, University of Virginia, Charlottesville, VA; 3Nephropath, Little Rock, AR; 4Pathology, Virginia Commonwealth University, Richmond, VA.

    Background:Calcineurin inhibitor nephrotoxicity (CNIT) is a well-known contributor to chronic allograft dysfunction in kidney transplant recipients (KTRs). Pediatric KTRs are particularly at risk given their…
  • 2016 American Transplant Congress

    Alemtuzumab Is Safe and Effective Induction Therapy in Highly Sensitized (HS) Pediatric Patients Undergoing Transplantation.

    I. Kim,1 J. Choi,1 A. Vo,1 A. Kang,1 M. Toyoda,1 J. Mirocha,2 E. Kamil,1 S. Louie,1 O. Galera,1 S. Jordan,1 D. Puliyanda.1

    1Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA; 2Biostatistics Core, Cedars-Sinai Medical Center, Los Angeles, CA.

    Introduction: Studies show that alemtuzumab, a potent lymphocyte-depleting agent, is well-tolerated in pediatric renal transplantation. We report on the use of alemtuzumab induction in HS…
  • 2016 American Transplant Congress

    Effect of Donor-Recipient Gender Mismatch in Liver Transplant Recipients: A Post-Hoc Analysis of the H2304 Study.

    L. Fischer, P. de Simone, G. Dong, P. Lopez, P. Bernhardt, F. Saliba.

    H2304 study group, Hamburg, Germany.

    Purpose: Donor-recipient gender mismatch may play a role in liver transplant (LTx) outcomes. Here we present the 24-month results from the post-hoc analysis of the…
  • 2016 American Transplant Congress

    Here Comes the Sun: Industry's Payments to Transplant Physicians.

    R. Ahmed,1 E. Chow,2 S. Bae,2 A. Massie,2 E. King,2 B. Orandi,2 J. Lopez,2 B. Lonze,2 D. Segev.2

    1Plastics and Reconstructive Surgery, Duke University Medical Center, Durham, NC; 2General Surgery, Johns Hopkins School of Medicine, Baltimore, MD.

    Background: The Open Payments Program (OPP) was implemented to publicly disclose industry payments to physicians, enabling patients to be aware of conflicts of interests. We…
  • 2016 American Transplant Congress

    Children Listed as Status 1B for Liver Transplantation Are Disenfranchised by MARS Therapy.

    A. Bakshi,1 M. Kueht,1 A. Rana,1,2 A. Akcan Arikan,3 J. Goss.1,2

    1Surgery, Division of Abdominal Transplantation and Hepatobiliry Surgery, Baylor College of Medicine, Houston, TX; 2Surgery, Division of Abdominal Transplantation, Texas Children's Hospital, Houston, TX; 3Pediatric Medicine, Intensive Care, Texas Children's Hospital, Houston, TX.

    Acute exacerbations of chronic liver failure in the pediatric population require advanced ICU care in order to survive to transplantation (OLT). Often, the patients are…
  • 2016 American Transplant Congress

    Growth of Liver Allografts in Pediatric Transplant Recipients.

    S. Chaudhry, J. Stern, S. Lobritto, M. Martinez, J. Vitorrio, J. Emond, T. Kato, B. Samstein, S. Bentley-Hibbert, A. Griesemer.

    Columbia University Medical Center, New York, NY.

    IntroductionThe liver's capacity to grow in response to metabolic need is well known. However, the long-term growth of liver allografts transplanted in pediatric patients has…
  • 2016 American Transplant Congress

    Incidence of Polyoma Virus Associated Nephropathy in a Single Transplant Center Employing a Reduction of Immunosuppression at a Lower Threshold of BK Viremia.

    M. Azar, A. Valika, D. Banach, I. Hall, M. Malinis.

    Internal Medicine, Infectious Diseases, Yale University, New Haven, CT.

    BackgroundPolyoma virus associated nephropathy (PyVAN) caused by BK virus (BKV) is a major complication occurring in 1-10% of renal transplant recipients. Screening and reduction of…
  • « Previous Page
  • 1
  • …
  • 141
  • 142
  • 143
  • 144
  • 145
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences